127 related articles for article (PubMed ID: 14680810)
1. TBBz but not TBBt discriminates between two molecular forms of CK2 in vivo and its implications.
Zień P; Abramczyk O; Domańska K; Bretner M; Szyszka R
Biochem Biophys Res Commun; 2003 Dec; 312(3):623-8. PubMed ID: 14680810
[TBL] [Abstract][Full Text] [Related]
2. Halogenated benzimidazole inhibitors of phosphorylation, in vitro and in vivo, of the surface acidic proteins of the yeast ribosomal 60S subunit by endogenous protein kinases CK-II and PK60S.
Szyszka R; Boguszewska A; Shugar D; Grankowski N
Acta Biochim Pol; 1996; 43(2):389-96. PubMed ID: 8862185
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of 4,5,6,7-tetrabromobenzimidazole as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources.
Zień P; Bretner M; Zastapiło K; Szyszka R; Shugar D
Biochem Biophys Res Commun; 2003 Jun; 306(1):129-33. PubMed ID: 12788077
[TBL] [Abstract][Full Text] [Related]
4. Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: evaluation of their effects on cells and different molecular forms of human CK2.
Zien P; Duncan JS; Skierski J; Bretner M; Litchfield DW; Shugar D
Biochim Biophys Acta; 2005 Dec; 1754(1-2):271-80. PubMed ID: 16203192
[TBL] [Abstract][Full Text] [Related]
5. Catalytic activity of mutants of yeast protein kinase CK2alpha.
Sajnaga E; Kubiński K; Szyszka R
Acta Biochim Pol; 2008; 55(4):767-76. PubMed ID: 19015772
[TBL] [Abstract][Full Text] [Related]
6. 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.
Pagano MA; Meggio F; Ruzzene M; Andrzejewska M; Kazimierczuk Z; Pinna LA
Biochem Biophys Res Commun; 2004 Sep; 321(4):1040-4. PubMed ID: 15358133
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2.
Najda-Bernatowicz A; Łebska M; Orzeszko A; Kopańska K; Krzywińska E; Muszyńska G; Bretner M
Bioorg Med Chem; 2009 Feb; 17(4):1573-8. PubMed ID: 19168362
[TBL] [Abstract][Full Text] [Related]
8. Differential phosphorylation of ribosomal acidic proteins from yeast cell by two endogenous protein kinases: casein kinase-2 and 60S kinase.
Szyszka R; Boguszewska A; Grankowski N; Ballesta JP
Acta Biochim Pol; 1995; 42(3):357-62. PubMed ID: 8588489
[TBL] [Abstract][Full Text] [Related]
9. Identification of protein kinase CK2 as a potent kinase of Epstein-Barr virus latent membrane protein 1.
Chi LM; Yu JS; Chang YS
Biochem Biophys Res Commun; 2002 Jun; 294(3):586-91. PubMed ID: 12056807
[TBL] [Abstract][Full Text] [Related]
10. Halogenated benzimidazoles and benzotriazoles as selective inhibitors of protein kinases CK I and CK II from Saccharomyces cerevisiae and other sources.
Szyszka R; Grankowski N; Felczak K; Shugar D
Biochem Biophys Res Commun; 1995 Mar; 208(1):418-24. PubMed ID: 7887958
[TBL] [Abstract][Full Text] [Related]
11. Ribosomal stalk protein phosphorylating activities in Saccharomyces cerevisiae.
Bou G; Remacha M; Ballesta JP
Arch Biochem Biophys; 2000 Mar; 375(1):83-9. PubMed ID: 10683252
[TBL] [Abstract][Full Text] [Related]
12. Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole.
Battistutta R; Mazzorana M; Sarno S; Kazimierczuk Z; Zanotti G; Pinna LA
Chem Biol; 2005 Nov; 12(11):1211-9. PubMed ID: 16298300
[TBL] [Abstract][Full Text] [Related]
13. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
Chojnacki K; Wińska P; Wielechowska M; Łukowska-Chojnacka E; Tölzer C; Niefind K; Bretner M
Bioorg Chem; 2018 Oct; 80():266-275. PubMed ID: 29966873
[TBL] [Abstract][Full Text] [Related]
14. Protein kinases phosphorylating acidic ribosomal proteins from yeast cells.
Szyszka R
Folia Microbiol (Praha); 1999; 44(2):142-52. PubMed ID: 10588049
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase CK2 activates the atypical Rio1p kinase and promotes its cell-cycle phase-dependent degradation in yeast.
Angermayr M; Hochleitner E; Lottspeich F; Bandlow W
FEBS J; 2007 Sep; 274(17):4654-67. PubMed ID: 17725716
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect and kinetic analysis of sodium quercetin-7,4'-disulphate on recombinant human protein kinase CK2 holoenzyme].
Liu XG; Liang NC; Liu W; She J; Mo LE
Yao Xue Xue Bao; 2002 Mar; 37(3):165-8. PubMed ID: 12579753
[TBL] [Abstract][Full Text] [Related]
17. Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases.
Cozza G; Sarno S; Ruzzene M; Girardi C; Orzeszko A; Kazimierczuk Z; Zagotto G; Bonaiuto E; Di Paolo ML; Pinna LA
Biochim Biophys Acta; 2013 Jul; 1834(7):1402-9. PubMed ID: 23360763
[TBL] [Abstract][Full Text] [Related]
18. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.
Leung KK; Shilton BH
Biochemistry; 2015 Jan; 54(1):47-59. PubMed ID: 25379648
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect and its kinetic analysis of tyrphostin AG1478 on recombinant human protein kinase CK2 holoenzyme.
Liu XG; Liang NC
Acta Pharmacol Sin; 2002 Jun; 23(6):556-61. PubMed ID: 12060532
[TBL] [Abstract][Full Text] [Related]
20. The raison d'être of constitutively active protein kinases: the lesson of CK2.
Pinna LA
Acc Chem Res; 2003 Jun; 36(6):378-84. PubMed ID: 12809523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
